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that the NKX2-5 mutants were associated with signiﬁcantly decreased transcriptional
activity compared with their wild-type counterpart.
Conclusions: The ﬁndings expand the spectrum of NKX2-5 mutations linked to AF
and provide additional evidence that dysfunctional NKX2-5 may confer vulnerability
to AF, suggesting the potential beneﬁt for the early prophylaxis and personalized
treatment of AF.
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Objectives: This study is designated to examine if and how ox-LDL triggers heart
failure.
Methods:We investigated the role of ox-LDL and LOX-1 in heart failure. Bax, Bcl-2
were detected by Real-time RT-PCR. In addition, LOX-1 was detected by western blot
analysis.
Results: Infusion of ox-LDL in mice for 4 weeks resulted in marked heart failure, as
characterized by an increase in heart size, heart /body weight ratio, and plasma BNP
levels, in conjunction with a lowered LV constriction function. Moreover, ox-LDL
treatment promoted apoptosis and upregulation of LOX-1 protein in both cultured
cardiomyocytes and murine hearts. Real-time RT-PCR ﬁndings revealed that ox-LDL
treatment increased Bax/Bcl-2 ratio in cardiomyocytes. Moreover, inhibition of LOX-
1 attenuated not only ox-LDL-induced cardiomyocyte apoptosis but also heart failure.
Conclusions: Our results indicate that ox-LDL triggers cardiomyocyte apoptosis and
heart failure possibly through LOX-1 and apoptosis.
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Objectives: This study investigated the effect of catheter-based renal sympathetic
denervation (RDN) on left ventricular remodeling and cardiac function in a porcine
model of heart failure induced by myocardial infarction.
Methods: Myocardial infarction was created by a percutaneous, permanent left
anterior descending artery occlusion in Chinese Guizhou miniature swine (n¼20).
After myocardial infarction, 12 pigs underwent bilateral RDN and 8 pigs served
as controls. Haemodynamic and echocardiographic data were measured at baseline
and 8 weeks after myocardial infarction. Infarct size, histological changes and
collagen volume fraction were evaluated after 8 weeks. Plasma norepinephrine, renin
activity, angiotensin II and cardiac angiotensin II were also determined by
radioimmunoassay.
Results: Compared with controls, RDN-treated pigs exhibited signiﬁcantly greater LV
ejection fraction (50.63.0% vs. 41.42.8%, P<0.01), systolic thickening fraction in
the infarcted LV wall, and maximum LV dP/dt, as well as lower LV end-diastolic
pressure. In addition, RDN reduced infarct size (7.70.9% vs. 12.92.1%, P<0.01)
and prevented cardiac hypertrophy and ﬁbrosis. What’s more, Plasma norepinephrine
concentration, renin activity, angiotensin II concentration and cardiac angiotensin II
level were decreased in RDN-treated pigs (P<0.05).
Conclusions: In this preclinical model of heart failure, renal sympathetic denervation
prevents left ventricular remodeling and improves cardiac function.
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Objectives: Structural and functional disruption of microvascular barrier caused by
ischemia/reperfusion results in uncontrolled inﬂammation and ischemia/reperfusion
injury (IRI). Hyperglycemia may aggravate myocardial IRI since it worsens the barrier
function. Whether Tongxinluo (TXL) is involved in reperfued diabetic heart protec-
tion through protecting cardiac microvascular endothelial cells (CMECs) is unknown.
In order to conﬁrm the effect and mechanism of TXL-mediated cardiac protection,
studies in vitro and in vivo were conducted.
Methods: HCMECs were cultured in normal (5.5mM) and high glucose (18mM)
for 48 h respectively followed by glucose-oxygen-serum deprivation (GOSD) for 2 h
and reoxygenation for 2 h. TXL (800mg/ml), PPAR-a inhibitor MK886 (1mM)
were supplemented. Endothelial monolayer permeability was assessed.VE-cadherin
internalization was detected by confocal microscope and western blotting.ICAM-1
expression was detected by western blotting.ZDF rats with Type 2 diabetes mellitus
(T2DM) underwent 45 min ligation and 3 h reperfusion of LAD. Vascular perme-
ability and infarct size were determined by FITC-dextran and TTC staining
seperately.C60 JACC Vol 64/16/Suppl C j OctobResults: Endothelial monolayer permeability was signiﬁcantly increased after the
GOSD/ reoxygenation treatment in a time and glucose concentration-dependent
manner. Compared with the control group, TXL dramatically decreased the ﬂuores-
cence intensity (1925138vs.3558133) and ICAM-1 expression, but remarkbly
increased the membrane/total VE-cadherin (35%4vs.84%6) in HCMECs. TXL
signiﬁcantly reduced ﬂuorescence intensity (2914388vs.4728483) and infarct size
(45%6vs.52%3) of ZDF rats with T2DM in AMI/reperfusion model compared
with control group. These protective effects of TXL were partly inhibited by MK886.
Conclusions: Accordingly, TXL protects reperfused diabetic heart through attenu-
ating VE-cadherin-mediated paracellular hyperpermeability via PPAR-a pathway.
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Objectives: Structural and functional disruption of microvascular barrier caused by
ischemia/reperfusion results in uncontrolled inﬂammation and ischemia/reperfusion
injury (IRI). Hyperglycemia may aggravate myocardial IRI since it worsens the barrier
function. Whether Tongxinluo (TXL) is involved in reperfused diabetic heart pro-
tection through protecting cardiac microvascular endothelial cells (CMECs) is un-
known. In order to conﬁrm the effect and mechanism of TXL-mediated cardiac
protection, studies in vitro and in vivo were conducted.
Methods: HCMECs were cultured in normal (5.5mM) and high glucose (18mM) for
48 h respectively followed by glucose-oxygen-serum deprivation (GOSD) for 2 h and
reoxygenation for 2 h. TXL (800mg/ml), PPAR-a inhibitor MK886 (1mM) were
supplemented. Endothelial monolayer permeability was assessed. VE-cadherin inter-
nalization was detected by confocal microscope and western blotting. ICAM-1
expression was detected by western blotting. ZDF rats with Type 2 diabetes mellitus
(T2DM) underwent 45 min ligation and 3 h reperfusion of LAD. Vascular perme-
ability and infarct size were determined by FITC-dextran and TTC staining
respectively.
Results: Endothelial monolayer permeability was signiﬁcantly increased after the
GOSD/ reoxygenation treatment in a time and glucose concentration-dependent
manner. Compared with the control group, TXL dramatically decreased the ﬂuores-
cence intensity (1925138 vs. 3558133) and ICAM-1 expression, but remarkably
increased the membrane/total VE-cadherin [ (354) % vs. (846) %] in HCMECs.
TXL signiﬁcantly reduced ﬂuorescence intensity (2914388 vs. 4728483) and
infarct size [ (456) % vs. (523) %] of ZDF rats with T2DM in AMI/reperfusion
model compared with control group. These protective effects of TXL were partly
inhibited by MK886.
Conclusions: Accordingly, TXL protects reperfused diabetic heart through attenu-
ating VE-cadherin-mediated paracellular hyperpermeability via PPAR-a pathway.
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Objectives: Coronary angiography (CAG) and percutaneous coronary intervention
(PCI) are widely used for coronary heart disease (CHD). However, these operations
are performed in the cardiac catheterization laboratory with X-rays. Although the
doctors can wear the heavy protective lead clothes to prevent X-ray radiation, they still
cannot avoid completely the harmful radiation. What’s more, some CAGs and PCIs
are difﬁcult because there are individual differences of coronary structure, which
needs to be operated ﬁnely. The possible robot-assistant manipulation will be great
useful in clinical practice. The study explored the feasibility and the validity of the
new robot operating system for CAG.
Methods: Pigs were anesthetized and 6F sheath was inserted into the femoral artery.
The 5F JR or JL catheter guide-wire was put manually into the sheath and the other
end was connected artiﬁcially with the robot arm. The robot system was controlled
outside of cardiac catheterization laboratory and the robot hand pushed the catheter
into aortic sinus. The catheter was adjusted carefully to forth-back and rotation by
manipulating the robot operating system. After the catheter was engaged well into the
coronary ostium, the robot hand injected the contrast into the coronary.
Results: The new robot operating system had a good control function for CAG. The
rotation angle can be ﬁne-tuned to 0.1 degrees, and the forth-back length can be ﬁne-
tuned to 0.1 mm. The ﬂow and the dose of contrast can be controlled accurately by
using the robot injection system. By manipulating robot system outside of cardiac
catheterization laboratory, we successfully completed the CAGs for 6 pigs without
exposure to X-rays. The operation duration from putting the catheter manually into the
sheath to ﬁnishing CAG was 8.21.2 min. All 6 pigs were survived after CAG.
Conclusions: The new robot operating system has the function of coronary catheter
transmission and rotation. Doctors can avoid or reduce the X-ray radiation exposure
during CAG by using this system. The robot operating system hopefully may become
a clinical advanced medical device for CAG and even PCI.er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
